Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trial.
Lancet. 2014.
PMID: 24268105
Free PMC article.
Clinical Trial.
Search Page
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 1804 | 1 |
| 1842 | 1 |
| 1845 | 1 |
| 1853 | 1 |
| 1857 | 1 |
| 1861 | 1 |
| 1862 | 1 |
| 1864 | 1 |
| 1867 | 1 |
| 1871 | 5 |
| 1880 | 2 |
| 1883 | 2 |
| 1888 | 1 |
| 1889 | 1 |
| 1894 | 1 |
| 1895 | 2 |
| 1904 | 1 |
| 1905 | 1 |
| 1906 | 1 |
| 1907 | 1 |
| 1908 | 2 |
| 1912 | 1 |
| 1914 | 1 |
| 1916 | 1 |
| 1919 | 1 |
| 1920 | 2 |
| 1921 | 1 |
| 1922 | 3 |
| 1923 | 1 |
| 1928 | 1 |
| 1930 | 1 |
| 1932 | 1 |
| 1933 | 2 |
| 1934 | 1 |
| 1936 | 2 |
| 1937 | 3 |
| 1938 | 1 |
| 1939 | 1 |
| 1940 | 4 |
| 1941 | 1 |
| 1944 | 1 |
| 1945 | 22 |
| 1946 | 107 |
| 1947 | 101 |
| 1948 | 95 |
| 1949 | 80 |
| 1950 | 155 |
| 1951 | 243 |
| 1952 | 346 |
| 1953 | 355 |
| 1954 | 300 |
| 1955 | 751 |
| 1956 | 3129 |
| 1957 | 4368 |
| 1958 | 4548 |
| 1959 | 4211 |
| 1960 | 4402 |
| 1961 | 5215 |
| 1962 | 3317 |
| 1963 | 540 |
| 1964 | 769 |
| 1965 | 734 |
| 1966 | 794 |
| 1967 | 1033 |
| 1968 | 1670 |
| 1969 | 1722 |
| 1970 | 1794 |
| 1971 | 1886 |
| 1972 | 2079 |
| 1973 | 2350 |
| 1974 | 2599 |
| 1975 | 2786 |
| 1976 | 2609 |
| 1977 | 2515 |
| 1978 | 3173 |
| 1979 | 3446 |
| 1980 | 3226 |
| 1981 | 2776 |
| 1982 | 3030 |
| 1983 | 3499 |
| 1984 | 3718 |
| 1985 | 3898 |
| 1986 | 4161 |
| 1987 | 4620 |
| 1988 | 6241 |
| 1989 | 7514 |
| 1990 | 8742 |
| 1991 | 9566 |
| 1992 | 10292 |
| 1993 | 11889 |
| 1994 | 11774 |
| 1995 | 12912 |
| 1996 | 13230 |
| 1997 | 14933 |
| 1998 | 15789 |
| 1999 | 16661 |
| 2000 | 17870 |
| 2001 | 18819 |
| 2002 | 20215 |
| 2003 | 23125 |
| 2004 | 25156 |
| 2005 | 27292 |
| 2006 | 29483 |
| 2007 | 31136 |
| 2008 | 33866 |
| 2009 | 35213 |
| 2010 | 38834 |
| 2011 | 42094 |
| 2012 | 45524 |
| 2013 | 50356 |
| 2014 | 59981 |
| 2015 | 67426 |
| 2016 | 73105 |
| 2017 | 77997 |
| 2018 | 83342 |
| 2019 | 90253 |
| 2020 | 105689 |
| 2021 | 111186 |
| 2022 | 102660 |
| 2023 | 99732 |
| 2024 | 62196 |
| 2025 | 6 |
Search Results
1,448,644 results
Results by year
Citations
2
articles
found by citation matching
Search results
Page 1
Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trial.
Lancet. 2014 Feb 15;383(9917):614-21. doi: 10.1016/S0140-6736(13)62302-8. Epub 2013 Nov 20.
Lancet. 2014.
PMID: 24268105
Free PMC article.
Clinical Trial.
BACKGROUND: The clinical benefit of preventive eradication of unruptured brain arteriovenous malformations remains uncertain. A Randomised trial of Unruptured Brain Arteriovenous malformations (ARUBA …
BACKGROUND: The clinical benefit of preventive eradication of unruptured brain arteriovenous malformations …
Medical management with interventional therapy versus medical management alone for unruptured brain arteriovenous malformations (ARUBA): final follow-up of a multicentre, non-blinded, randomised controlled trial.
Lancet Neurol. 2020 Jul;19(7):573-581. doi: 10.1016/S1474-4422(20)30181-2.
Lancet Neurol. 2020.
PMID: 32562682
Clinical Trial.
BACKGROUND: In A Randomized trial of Unruptured Brain Arteriovenous malformations (ARUBA), randomisation was halted at a mean follow-up of 33.3 months after a prespecified interim analysis showed that medical manag …
BACKGROUND: In A Randomized trial of Unruptured Brain Arteriovenous malformations (ARUBA), …
A review on advances of treatment modalities for Alzheimer's disease.
Life Sci. 2021 Jul 1;276:119129. doi: 10.1016/j.lfs.2021.119129. Epub 2021 Jan 27.
Life Sci. 2021.
PMID: 33515559
Review.
Alzheimer's disease (AD) is a multifactorial neurodegenerative disease which is mainly characterized by progressive impairment in cognition, emotion, language and memory in older population. ...In this review, we provide a brief introduction on the background of Alz …
Alzheimer's disease (AD) is a multifactorial neurodegenerative disease which is mainly characterized by progressive impairment …
A new taxonomy for describing and defining adherence to medications.
Br J Clin Pharmacol. 2012 May;73(5):691-705. doi: 10.1111/j.1365-2125.2012.04167.x.
Br J Clin Pharmacol. 2012.
PMID: 22486599
Free PMC article.
Review.
'Adherence to medications' is the process by which patients take their medication as prescribed, further divided into three quantifiable phases: 'Initiation', 'Implementation' and 'Discontinuation'. ...The terms and definitions are focused on promoting consistency a …
'Adherence to medications' is the process by which patients take their medication as prescribed, further divided into three qu …
Effect of bar-code technology on the safety of medication administration.
N Engl J Med. 2010 May 6;362(18):1698-707. doi: 10.1056/NEJMsa0907115.
N Engl J Med. 2010.
PMID: 20445181
Free article.
Clinical Trial.
BACKGROUND: Serious medication errors are common in hospitals and often occur during order transcription or administration of medication. To help prevent such errors, technology has been developed to verify medications by incorporating bar-code verific …
BACKGROUND: Serious medication errors are common in hospitals and often occur during order transcription or administration of …
Team Up!
J Am Coll Cardiol. 2017 Apr 11;69(14):1871-1872. doi: 10.1016/j.jacc.2017.03.007.
J Am Coll Cardiol. 2017.
PMID: 28385316
Free article.
No abstract available.
Light-triggered nanoparticles for pain management.
Expert Opin Drug Deliv. 2020 May;17(5):627-633. doi: 10.1080/17425247.2020.1737670. Epub 2020 Mar 5.
Expert Opin Drug Deliv. 2020.
PMID: 32116072
Review.
Introduction: Recent technological progress in pain management includes patients stratification depending on their disease subtype, prognosis, risk, or treatment response using data analysis and genetic testing in order to select the most appropriate drug for each g …
Introduction: Recent technological progress in pain management includes patients stratification depending on their disease sub …
Managing hyponatremia.
JAAPA. 2019 Oct;32(10):48-50. doi: 10.1097/01.JAA.0000578796.15417.09.
JAAPA. 2019.
PMID: 31567743
Review.
Despite the high incidence of hyponatremia, the correct approach to management, particularly in patients with severe hyponatremia (serum sodium of 120 mEq/L or less), is controversial. ...
Despite the high incidence of hyponatremia, the correct approach to management, particularly in patients with severe hyponatremia (se …
Pediatric Ingestions: Emergency Department Management.
Pediatr Emerg Med Pract. 2016 Apr;13(4):1-24; quiz 20. Epub 2016 Apr 1.
Pediatr Emerg Med Pract. 2016.
PMID: 27104813
Review.
Evidence regarding the evaluation and management of common pediatric ingestions is comprised largely of case reports and retrospective studies. ...Also discussed are current recommendations for decontamination, administration of antidotes for specific toxins, and …
Evidence regarding the evaluation and management of common pediatric ingestions is comprised largely of case reports and retrospectiv …
Anaphylaxis to drugs.
Immunol Allergy Clin North Am. 2015 May;35(2):303-19. doi: 10.1016/j.iac.2015.01.008. Epub 2015 Mar 3.
Immunol Allergy Clin North Am. 2015.
PMID: 25841553
Review.
Cite